Ankylosing Spondylitis PBMC
About: Ankylosing Spondylitis PBMC samples are isolated from donors with clinically confirmed ankylosing spondylitis. Ideal for studying T cell activity, HLA-B27–associated immune responses, and chronic inflammation in axial spondyloarthritis.
| Lot Number | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 77504 | Ankylosing Spondylitis | 10M | African American | 67 | Female |
Gabapentin 100 mg TID Enulose Solution Eye Drops TID Timolol 1 gtt QD Kerendia 10 mg QD Adalimumab Injection Q 2 Weeks Rosuvastatin 20 mg QD Esomeprazole 40 mg QD Estradiol 0.1 mg Vaginal Cream Amlodipine-Olmesartan 20/40 mg QD
|
5 | |||
| 77063 | Ankylosing Spondylitis | 10M | Caucasian | 68 | Female |
Skyrizi - 360 ml monthly Lisinopril - 0.075 daily Pantoprazole - 20 mg daily Atorvastatin - 20 mg daily Lamotrigine - 150 mg daily Seroquel - 100mg daily Trazadone - 100 mg daily
|
121 | |||
| 74686 | Ankylosing Spondylitis | 50M | Caucasian | 60 | Female |
Simponi Inf Q6W Chlorthalidone 12.5 mg QD Zepbound 10 mg QW Methimazole 5 mg QOD Rosuvastatin 5 mg QD Lefluonimide 20 mg QOD Potassium Chloride 20 mEq BID Vitamin B Vitamin D
|
124 | $1,208.00 | ||
| 72201 | Ankylosing Spondylitis | 10M | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
13 | |||
| 71615 | Ankylosing Spondylitis | 10M | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
3 | |||
| 77876 | Ankylosing Spondylitis | 5M | Caucasian | 62 | Male |
Taltz/80mg/mL/QM Celebrex/200mg/PRN ( has not taken it in long time) Sulfalsalizine QD
|
1 | $765.00 | ||
| 77419 | Ankylosing Spondylitis | 3M | Caucasian | 46 | Male |
Duloxetine 60 mg QD Remicade Q8 weeks Methotrexate 7.5 mg QD Folic Acid 1 mg QD Modafinil 100 mg QD Olmesartan 40/25 mg QD Meloxicam 15 mg QD
|
1 | |||
| 77405 | Ankylosing Spondylitis | 10M | Hispanic/Latino | 43 | Female |
None Not taking any medications for hypertension.
|
6 | |||
| 76540 | Ankylosing Spondylitis | 10M | Caucasian | 54 | Female |
Rosuvastatin 40 MG tablet, metoPROLOL succinate 25 MG 24 hr tablet, losartan 50 MG tablet, ezetimibe 10 MG tablet, fluoxetine 60 MG capsule Voquezna 20 MG Tab gabapentin 100 MG capsule Quetiapine 25 MG tablet Xeljanz XR 11 MG TABLET SR 24 HR Phentermine 37.5 mcg QD
|
11 | |||
| 71399 | Ankylosing Spondylitis | 50M | Caucasian | 82 | Male | United States (US) |
Celecoxib 200mg QD Gabapentin 600mg BID Atorvastatin 20mg QD Metoprolol 25mg QD Tamsulosin 0.4mg QD
|
106 | $1,208.00 |
High-Quality Ankylosing Spondylitis PBMC for Research
Ankylosing Spondylitis PBMC products are sourced from donors clinically diagnosed with Ankylosing Spondylitis and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on disease-specific immune dysregulation, T cell subsets, and cytokine production.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed Ankylosing Spondylitis donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified Ankylosing Spondylitis diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional ankylosing spondylitis-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in ankylosing spondylitis pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Ankylosing Spondylitis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.